Growth in salaries for private company life sciences executives continued to outpace growth for comparable technology leaders. Executives in both industries saw stronger salary growth in 2014 than 2013.
BOSTON, MA (October 7, 2014)—According to an executive compensation study of private businesses released today, non-founder C-suite executives at life sciences and healthcare companies saw their cash compensation increase by 4.2 percent year-over-year, while comparable executives at private technology firms experienced an average increase of 3 percent.
The CompStudy, now in its 15th year, also revealed compensation levels and trends for specific functional roles. In terms of target bonuses, non-founder CEOs at private technology companies surveyed saw flat bonus targets between 2013 and 2014, with the average holding at just over $130,000. Technology CEOs saw their base salaries grow by an average of 2.9 percent, up to $249,000 in 2014. CEOs at private life sciences firms surveyed also experienced no change in bonuses and a 4.1 percent increase in base salaries, bringing their average bonus and base up to $107,000 and $299,000, respectively. While these averages cut across a wide swatch of company types and stages, more granular reports can be generated by registering at www.compstudy.com.
On prior-year bonus attainment, life sciences non-founder CEOs fared equally as well as their technology counterparts. Life sciences CEOs received, on average, 61.3 percent of their at-plan cash bonus. Technology non-founder CEOs received 60.2 percent of their comparable target.
The CompStudy is produced by Park Square Executive Search in collaboration with Professor Noam Wasserman of the Harvard Business School, and is sponsored by Ernst & Young, LLP and the law firm WilmerHale. The 2014 CompStudy survey includes nearly 800 private companies and data on more than 4,000 executives.
“Over the past year, we have seen an increase in target cash compensation of more than 4 percent among CXOs at private life sciences companies. This growth continues to build on the compensation recovery that started in 2012, after we saw the lowest growth in CompStudy history during the recent economic downturn. This year, M&A activity is up, the IPO window is open, good companies are still getting funded, and the war for talent appears to be alive and well,” said Erik Lundh, Managing Partner, Park Square Executive Search.
“The technology and healthcare sectors have had a record year with companies expanding their capabilities and innovating for explosive growth. The fact that employees in these sectors have seen an average increase of 3 to 3.5% in their total compensation is a testament to the fact that companies are rewarding for talent that is able to drive scalability,” said Bryan Pearce Global Leader, EY Entrepreneur Of The Year™ and Venture Capital.
The study is the most comprehensive survey of executive compensation among privately-held, emerging technology and life sciences companies and the first to make this information readily available. The results are used as an authoritative guide by venture capital firms and their portfolio companies to make critical decisions regarding attracting, rewarding and retaining key talent.
"The CompStudy data that we work with Park Square and EY to make available annually has proven to be a valuable tool for boards as they begin making decisions about this year’s bonuses and looking ahead to next year’s budgeting needs,” said Kimberly Wethly, Chair of WilmerHale’s Tax Group. “Having this window into the marketplace helps boards to ensure that they remain competitive.”
Study results are available at www.compstudy.com and will be explained in detail on Wednesday, October 8, 2014, during two separate technology- and life sciences-focused webcasts. The webcasts, led by senior practitioners at Park Square, EY and WilmerHale, will discuss how life sciences and technology companies have reacted to the state of the economy and what the future might hold for these VC-backed companies. Click here to register.
Nearly 800 privately-held, emerging technology and life sciences companies throughout the United States took part in the survey, which delved into the compensation, bonus and equity packages of top executive positions, including Chief Executive Officer, President/Chief Operating Officer and Chief Financial Officer. The data was analyzed in aggregate with detailed views by position looking at: industry vertical, product stage, revenue, headcount, geography, founder status and financing stage. More than 85 percent of the surveyed companies have fewer than 75 employees.
Park Square Executive Search
Park Square Executive Search is a retainer-based executive search firm located in Cambridge, Massachusetts and in Menlo Park, California. Park Square serves clients and institutions that are changing the world through discovery, innovation, and growth. More information about the firm can be found at http://www.parksquaresearch.com.
EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.
EY refers to the global organization and may refer to one or more of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit ey.com.
This news release has been issued by EYGM Limited, a member of the global EY organization that also does not provide any services to clients.
About Wilmer Cutler Pickering Hale and Dorr LLP
WilmerHale provides legal representation across a comprehensive range of practice areas that are critical to the success of its clients. The law firm’s leading Intellectual Property, Litigation/Controversy, Regulatory and Government Affairs, Securities, and Corporate and Transactional Departments participate in some of the highest-profile legal and policy matters. With a staunch commitment to public service, the firm is renowned as a leader in pro bono representation. WilmerHale is 1,000 lawyers strong with 14 offices in the United States, Europe and Asia. For more information, please visit www.wilmerhale.com.